MedPath

Obesity and Liver Function in Oesophageal Cancer

Conditions
Liver Function
Obesity
Registration Number
NCT04152044
Lead Sponsor
St. James's Hospital, Ireland
Brief Summary

There is an established link between sarcopenia and outcomes in oesophageal cancer. There is scant reports in the literature regarding the influences of different obesity in different compartments.

Detailed Description

Oesophageal cancer rates are increasing as a result of obesity in Western society. Thr investigators are evaluating the influence of viscerala dn subcutaneous obesity on overall outcomes of the participants. In addition the investigators are evaluating if there is a correlation with Liver Function Tests and liver histopathology such as steatosis on survival in participants and post operative sequele.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
658
Inclusion Criteria
  • Those undergoing oesophagectomy
Exclusion Criteria
  • patients who only had chemotherapy/chemoradiotherapy without surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease free survival1 year
Overall Survival1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St. James's Hospital

🇮🇪

Dublin, IE, Ireland

St. James's Hospital
🇮🇪Dublin, IE, Ireland
Noel E Donlon
Contact
00353863557726
donlonn@tcd.ie

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.